Radioiodine-Refractory Differentiated Thyroid Carcinoma in Children and Adolescents: A Retrospective Study
Problems of Endocrinology · 22.07.2026 · 72 (3) · 66-79
DOI: 10.14341/probl13649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Endocrinology, online erschienen am 22.07.2026. Verfasst von K Yu Slaschuk und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Endocrinology named after Academician I.I. Dedov. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Iodine Radioisotopes. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND : Differentiated thyroid carcinoma (DTC) in children is a rare malignancy characterized by a high propensity for regional and distant metastases yet generally associated with a favorable long-term prognosis. Radioiodine-refractory (RAIR) disease represents a distinct clinical challenge, accounting for approximately 10–30% of pediatric DTC cases, and warrants comprehensive investigation of its clinical course, prognostic factors, and therapeutic options. This study aimed to perform an integrated assessment of treatment outcomes in children undergoing combined therapy for DTC (surgery and radioiodine therapy, RAI), with a particular focus on advanced and RAIR disease. MATERIALS AND METHODS : We retrospectively analyzed medical records of 278 patients aged 5–18 years who underwent primary surgical treatment between 2008 and 2022, followed by one or more courses of RAI at the Endocrinology Research Centre (Moscow, Russia) from December 2015 to March 2024. The study included patients with advanced disease (high risk of recurrence at diagnosis) fulfilling at least one RAIR criterion, with a median follow-up of 48.0 months [21.5; 62.0]. RESULTS: Among 278 patients, 39 (14%) were diagnosed with advanced disease. Of these, 4 achieved remissions, 29 had stable disease, and 6 experienced biochemical and/or structural progression. Progression-free survival in the RAIR cohort was 85%, while the 5-year overall survival reached 100%. CONCLUSION : Based on study findings, we propose a novel classification system integrating both the baseline ability of metastases to accumulate ¹³¹I and the dynamic response to RAI (progression vs. stabilization). This framework is designed to optimize treatment and follow-up algorithms. The management of RAIR pediatric DTC should remain balanced: avoiding overtreatment in stable disease, while ensuring timely initiation of modern systemic therapies in patients with risk factors for progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Medical Research Center for Endocrinology named after Academician I.I. Dedov.
- My Medical Center High Technologies.
- N.N. Burdenko National Medical Research Center for Neurosurgery.
- Saint Petersburg State University.
Zitieren
APA
Slaschuk, K. Y., Reinberg, M. V., Rumyantsev, P. O., Nikiforovich, P. A., Konokikhina, A. P., Pershina-Milyutina, A. P., Aredov, A. V., Sheremeta, M. S., Degtyarev, M. V., Trukhin, A. A., Chikulaeva, O. A., Nagaeva, E. V., Brovin, D. N., Chernikov, R. A., Bezlepkina, O. B., Peterkova, V. A., Mokrysheva, N. G., & Dedov, I. I. (2026). Radioiodine-Refractory Differentiated Thyroid Carcinoma in Children and Adolescents: A Retrospective Study. Problems of Endocrinology, 72(3), 66-79. https://doi.org/10.14341/probl13649
Vancouver
Slaschuk KY, Reinberg MV, Rumyantsev PO, Nikiforovich PA, Konokikhina AP, Pershina-Milyutina AP, et al. Radioiodine-Refractory Differentiated Thyroid Carcinoma in Children and Adolescents: A Retrospective Study. Problems of Endocrinology. 2026;72(3):66-79. doi:10.14341/probl13649
BibTeX
@article{Slaschuk2026,
author = {Slaschuk, K Yu and Reinberg, M V and Rumyantsev, P O and Nikiforovich, P A and Konokikhina, A P and Pershina-Milyutina, A P and Aredov, A V and Sheremeta, M S and Degtyarev, M V and Trukhin, A A and Chikulaeva, O A and Nagaeva, E V and Brovin, D N and Chernikov, R A and Bezlepkina, O B and Peterkova, V A and Mokrysheva, N G and Dedov, I I},
title = {Radioiodine-Refractory Differentiated Thyroid Carcinoma in Children and Adolescents: A Retrospective Study},
journal = {Problems of Endocrinology},
year = {2026},
volume = {72},
number = {3},
pages = {66--79},
doi = {10.14341/probl13649}
}
EUVIMED